Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Boutron

Showing results (21-30 of 290) with videos related to

Pageof 29
Sort By:
JAMA Internal Medicine|August 4, 2025
Clarifying Correction Status in Retracted Study Analysis-ReplyIsabelle Boutron, Lina Ghosn, Carolina Graña Possamai
JAMA Internal Medicine|June 28, 2021
Osteopathic Manipulative Treatment for Chronic Low Back Pain-ReplyChristelle Nguyen, Rafael Zegarra-Parodi, Isabelle Boutron
Journal of Clinical Epidemiology|October 12, 2022
The Global Evidence Commission's report provided a wake-up call for the evidence communityRuth Stewart, Isabelle Boutron, Elie A Akl
Journal of Clinical Epidemiology|April 9, 2008
The account for provider and center effects in multicenter interventional and surgical randomized controlled trials is in need of improvement: a reviewDavid J Biau, Raphaël Porcher, Isabelle Boutron
Journal of Clinical Epidemiology|September 23, 2021
Secondary electronic sources demonstrated very good sensitivity for identifying studies evaluating interventions for COVID-19Olivier Pierre, Carolina Riveros, Sarah Charpy, et al.
Journal of Clinical Epidemiology|April 4, 2019
The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analysesIgnacio Atal, Raphaël Porcher, Isabelle Boutron, et al.
Arthritis and Rheumatism|June 4, 2005
Violation of the intent-to-treat principle and rate of missing data in superiority trials assessing structural outcomes in rheumatic diseasesGabriel Baron, Isabelle Boutron, Bruno Giraudeau, et al.
Annals of the Rheumatic Diseases|December 13, 2006
Reporting of radiographic methods in randomised controlled trials assessing structural outcomes in rheumatoid arthritisGabriel Baron, Isabelle Boutron, Bruno Giraudeau, et al.
Journal of Clinical Epidemiology|January 13, 2009
Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposalAgnes Dechartres, Isabelle Boutron, Carine Roy, et al.
BMJ (Clinical Research Ed.)|November 6, 2014
Authors' reply to O'Neill and colleaguesAnnabel Maruani, Isabelle Boutron, Gabriel Baron, et al.
Pageof 29

Showing results (21-30 of 290) with videos related to

Sort By:
Pageof 29
JAMA Internal Medicine|August 4, 2025
Clarifying Correction Status in Retracted Study Analysis-ReplyIsabelle Boutron, Lina Ghosn, Carolina Graña Possamai
JAMA Internal Medicine|June 28, 2021
Osteopathic Manipulative Treatment for Chronic Low Back Pain-ReplyChristelle Nguyen, Rafael Zegarra-Parodi, Isabelle Boutron
Journal of Clinical Epidemiology|October 12, 2022
The Global Evidence Commission's report provided a wake-up call for the evidence communityRuth Stewart, Isabelle Boutron, Elie A Akl
Journal of Clinical Epidemiology|April 9, 2008
The account for provider and center effects in multicenter interventional and surgical randomized controlled trials is in need of improvement: a reviewDavid J Biau, Raphaël Porcher, Isabelle Boutron
Journal of Clinical Epidemiology|September 23, 2021
Secondary electronic sources demonstrated very good sensitivity for identifying studies evaluating interventions for COVID-19Olivier Pierre, Carolina Riveros, Sarah Charpy, et al.
Journal of Clinical Epidemiology|April 4, 2019
The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analysesIgnacio Atal, Raphaël Porcher, Isabelle Boutron, et al.
Arthritis and Rheumatism|June 4, 2005
Violation of the intent-to-treat principle and rate of missing data in superiority trials assessing structural outcomes in rheumatic diseasesGabriel Baron, Isabelle Boutron, Bruno Giraudeau, et al.
Annals of the Rheumatic Diseases|December 13, 2006
Reporting of radiographic methods in randomised controlled trials assessing structural outcomes in rheumatoid arthritisGabriel Baron, Isabelle Boutron, Bruno Giraudeau, et al.
Journal of Clinical Epidemiology|January 13, 2009
Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposalAgnes Dechartres, Isabelle Boutron, Carine Roy, et al.
BMJ (Clinical Research Ed.)|November 6, 2014
Authors' reply to O'Neill and colleaguesAnnabel Maruani, Isabelle Boutron, Gabriel Baron, et al.
Pageof 29